Last reviewed · How we verify
Vyvanse
At a glance
| Generic name | Vyvanse |
|---|---|
| Also known as | lisdexamfetamine dimesylate, lisdexamfatamine dimesylate (LDX), Lisdexamphetamine is marketed as Vyvanse, Lisdexamfetamine |
| Sponsor | Vanderbilt University |
| Target | Sodium-dependent dopamine transporter, Sodium-dependent noradrenaline transporter, Synaptic vesicular amine transporter |
| Modality | Small molecule |
| Therapeutic area | Nephrology |
| Phase | FDA-approved |
Approved indications
- Attention deficit hyperactivity disorder
- Binge eating disorder
Common side effects
- Decreased appetite
- Upper abdominal pain
- Vomiting
- Weight decreased
- Nausea
- Dry mouth
- Dizziness
- Irritability
- Insomnia
- Anxiety
- Dyspnea
- Fatigue
Key clinical trials
- A Trial to Assess How Centanafadine Interacts With Stimulants in the Body (PHASE1)
- Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder (PHASE2)
- Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users (PHASE2)
- Pharmacological and Behavioral Treatment After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b) (PHASE2, PHASE3)
- Vyvanse in Children Aged 6 to 12 Years (EARLY_PHASE1)
- Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Maintenance Treatment (PHASE3)
- Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder (PHASE2)
- Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vyvanse CI brief — competitive landscape report
- Vyvanse updates RSS · CI watch RSS
- Vanderbilt University portfolio CI